Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-05 Drugs for erectile dysfunction
Links
FSRH Clinical Guideline: Contraceptive Choices for Young People- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
Generic sildenafil (QIPP) information - Generic sildenafil (QIPP) information supporting information
- LSCMMG: Primary Care Management of Erectile Dysfunction
- LSCMMG: Primary Care Management of Erectile Dysfunction
- LSCMMG: Primary Care Management of Overactive Bladder in Female Adults
- MHRA Drug Safety Update Nov 2018: Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management
- NICE TA273: Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)
- NICE: Hyperplasia (benign prostatic) - tadalafil (terminated appraisal) (TA273)